Global Recombinant Hepatitis B Vaccine Market Research Report 2022

Global Recombinant Hepatitis B Vaccine Market Research Report 2022

Table of Contents
1 Recombinant Hepatitis B Vaccine Market Overview
1.1 Product Overview and Scope of Recombinant Hepatitis B Vaccine
1.2 Recombinant Hepatitis B Vaccine Segment by Type
1.2.1 Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Recombinant Hepatitis B Vaccine Segment by Application
1.3.1 Global Recombinant Hepatitis B Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Global Recombinant Hepatitis B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant Hepatitis B Vaccine Revenue 2017-2028
1.4.2 Global Recombinant Hepatitis B Vaccine Sales 2017-2028
1.4.3 Recombinant Hepatitis B Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Recombinant Hepatitis B Vaccine Market Competition by Manufacturers
2.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Recombinant Hepatitis B Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Recombinant Hepatitis B Vaccine Market Competitive Situation and Trends
2.5.1 Recombinant Hepatitis B Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant Hepatitis B Vaccine Players Market Share by Revenue
2.5.3 Global Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Hepatitis B Vaccine Retrospective Market Scenario by Region
3.1 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Recombinant Hepatitis B Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.3.1 North America Recombinant Hepatitis B Vaccine Sales by Country
3.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.4.1 Europe Recombinant Hepatitis B Vaccine Sales by Country
3.4.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant Hepatitis B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region
3.5.2 Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Recombinant Hepatitis B Vaccine Sales by Country
3.6.2 Latin America Recombinant Hepatitis B Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant Hepatitis B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country
3.7.2 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Recombinant Hepatitis B Vaccine Historic Market Analysis by Type
4.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022)
5 Global Recombinant Hepatitis B Vaccine Historic Market Analysis by Application
5.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Recombinant Hepatitis B Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 CSL Limited
6.5.1 CSL Limited Corporation Information
6.5.2 CSL Limited Description and Business Overview
6.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CSL Limited Recombinant Hepatitis B Vaccine Product Portfolio
6.5.5 CSL Limited Recent Developments/Updates
6.6 Emergent Biosolutions
6.6.1 Emergent Biosolutions Corporation Information
6.6.2 Emergent Biosolutions Description and Business Overview
6.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolio
6.6.5 Emergent Biosolutions Recent Developments/Updates
6.7 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments/Updates
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Corporation Information
6.8.2 Johnson & Johnson Description and Business Overview
6.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolio
6.8.5 Johnson & Johnson Recent Developments/Updates
6.9 Hualan Biological Engineering
6.9.1 Hualan Biological Engineering Corporation Information
6.9.2 Hualan Biological Engineering Description and Business Overview
6.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolio
6.9.5 Hualan Biological Engineering Recent Developments/Updates
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description and Business Overview
6.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 NCPC Recombinant Hepatitis B Vaccine Product Portfolio
6.10.5 NCPC Recent Developments/Updates
6.11 China National Biotec Group
6.11.1 China National Biotec Group Corporation Information
6.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Description and Business Overview
6.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolio
6.11.5 China National Biotec Group Recent Developments/Updates
6.12 Dalian Hissen Bio-pharm
6.12.1 Dalian Hissen Bio-pharm Corporation Information
6.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Description and Business Overview
6.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolio
6.12.5 Dalian Hissen Bio-pharm Recent Developments/Updates
6.13 Beijing Tiantan Biological
6.13.1 Beijing Tiantan Biological Corporation Information
6.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Description and Business Overview
6.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolio
6.13.5 Beijing Tiantan Biological Recent Developments/Updates
7 Recombinant Hepatitis B Vaccine Manufacturing Cost Analysis
7.1 Recombinant Hepatitis B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
7.4 Recombinant Hepatitis B Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant Hepatitis B Vaccine Distributors List
8.3 Recombinant Hepatitis B Vaccine Customers
9 Recombinant Hepatitis B Vaccine Market Dynamics
9.1 Recombinant Hepatitis B Vaccine Industry Trends
9.2 Recombinant Hepatitis B Vaccine Market Drivers
9.3 Recombinant Hepatitis B Vaccine Market Challenges
9.4 Recombinant Hepatitis B Vaccine Market Restraints
10 Global Market Forecast
10.1 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Type (2023-2028)
10.2 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Application (2023-2028)
10.3 Recombinant Hepatitis B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant Hepatitis B Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Recombinant Hepatitis B Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Recombinant Hepatitis B Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Recombinant Hepatitis B Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Recombinant Hepatitis B Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Recombinant Hepatitis B Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Recombinant Hepatitis B Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Recombinant Hepatitis B Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Recombinant Hepatitis B Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant Hepatitis B Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant Hepatitis B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Hepatitis B Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Recombinant Hepatitis B Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Recombinant Hepatitis B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Recombinant Hepatitis B Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Recombinant Hepatitis B Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Recombinant Hepatitis B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck Recombinant Hepatitis B Vaccine Product
Table 53. Merck Recent Developments/Updates
Table 54. GlaxoSmithKline Plc Corporation Information
Table 55. GlaxoSmithKline Plc Description and Business Overview
Table 56. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product
Table 58. GlaxoSmithKline Plc Recent Developments/Updates
Table 59. Pfizer Inc. Corporation Information
Table 60. Pfizer Inc. Description and Business Overview
Table 61. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Pfizer Inc. Recombinant Hepatitis B Vaccine Product
Table 63. Pfizer Inc. Recent Developments/Updates
Table 64. Sanofi Pasteur Corporation Information
Table 65. Sanofi Pasteur Description and Business Overview
Table 66. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product
Table 68. Sanofi Pasteur Recent Developments/Updates
Table 69. CSL Limited Corporation Information
Table 70. CSL Limited Description and Business Overview
Table 71. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. CSL Limited Recombinant Hepatitis B Vaccine Product
Table 73. CSL Limited Recent Developments/Updates
Table 74. Emergent Biosolutions Corporation Information
Table 75. Emergent Biosolutions Description and Business Overview
Table 76. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product
Table 78. Emergent Biosolutions Recent Developments/Updates
Table 79. Serum Institute of India Corporation Information
Table 80. Serum Institute of India Description and Business Overview
Table 81. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Serum Institute of India Recombinant Hepatitis B Vaccine Product
Table 83. Serum Institute of India Recent Developments/Updates
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Business Overview
Table 86. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Johnson & Johnson Recombinant Hepatitis B Vaccine Product
Table 88. Johnson & Johnson Recent Developments/Updates
Table 89. Hualan Biological Engineering Corporation Information
Table 90. Hualan Biological Engineering Description and Business Overview
Table 91. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product
Table 93. Hualan Biological Engineering Recent Developments/Updates
Table 94. NCPC Corporation Information
Table 95. NCPC Description and Business Overview
Table 96. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. NCPC Recombinant Hepatitis B Vaccine Product
Table 98. NCPC Recent Developments/Updates
Table 99. China National Biotec Group Corporation Information
Table 100. China National Biotec Group Description and Business Overview
Table 101. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. China National Biotec Group Recombinant Hepatitis B Vaccine Product
Table 103. China National Biotec Group Recent Developments/Updates
Table 104. Dalian Hissen Bio-pharm Corporation Information
Table 105. Dalian Hissen Bio-pharm Description and Business Overview
Table 106. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product
Table 108. Dalian Hissen Bio-pharm Recent Developments/Updates
Table 109. Beijing Tiantan Biological Corporation Information
Table 110. Beijing Tiantan Biological Description and Business Overview
Table 111. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product
Table 113. Beijing Tiantan Biological Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Recombinant Hepatitis B Vaccine Distributors List
Table 117. Recombinant Hepatitis B Vaccine Customers List
Table 118. Recombinant Hepatitis B Vaccine Market Trends
Table 119. Recombinant Hepatitis B Vaccine Market Drivers
Table 120. Recombinant Hepatitis B Vaccine Market Challenges
Table 121. Recombinant Hepatitis B Vaccine Market Restraints
Table 122. Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 123. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 124. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 125. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 126. Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 127. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 128. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 129. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 130. Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 131. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 132. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 133. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Hepatitis B Vaccine
Figure 2. Global Recombinant Hepatitis B Vaccine Market Share by Type in 2021 & 2028
Figure 3. 10mcg/ml Product Picture
Figure 4. 10mcg/0.5ml Product Picture
Figure 5. Global Recombinant Hepatitis B Vaccine Market Share by Application in 2021 & 2028
Figure 6. Newborn
Figure 7. Primary School Students
Figure 8. Adult
Figure 9. Global Recombinant Hepatitis B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Recombinant Hepatitis B Vaccine Market Size (2017-2028) & (US$ Million)
Figure 11. Global Recombinant Hepatitis B Vaccine Sales (2017-2028) & (K Units)
Figure 12. Recombinant Hepatitis B Vaccine Sales Share by Manufacturers in 2021
Figure 13. Global Recombinant Hepatitis B Vaccine Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Recombinant Hepatitis B Vaccine Players: Market Share by Revenue in 2021
Figure 15. Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
Figure 17. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2021
Figure 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
Figure 19. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region in 2021
Figure 20. U.S. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Recombinant Hepatitis B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Recombinant Hepatitis B Vaccine by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Recombinant Hepatitis B Vaccine
Figure 46. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure 47. Recombinant Hepatitis B Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs